Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01310699 · ClinicalTrials.gov registry record · NA

Study of Flat Polyp Detection Using New Narrow Band Imaging (NBI) Compared to White Light Colonoscopy - The FIND FLAT Colonoscopy Study

A NA study of Colorectal Cancer and Colorectal Neoplasms, sponsored by VA Palo Alto Health Care System.

Completed
Registry status
NA
Development phase
281
Enrollment target
3
Study locations

NCT01310699 is a NA study of Colorectal Cancer and Colorectal Neoplasms that has completed, run by VA Palo Alto Health Care System. The registered enrollment target is 281 participants, below the 1,510-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (81% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01310699, a NA study of Colorectal Cancer and Colorectal Neoplasms, has completed, sponsored by VA Palo Alto Health Care System.

COMPLETED
Registry status
NA
Development phase
281 participants
Enrollment target
3
Study locations

Study Summary

We hypothesize that high definition narrow band imaging (NBI) colonoscopy compared to high definition white light colonoscopy will detect an increased number of nonpolypoid (flat and depressed) colorectal neoplasm.

Interventions

  • DEVICE Olympus Colonoscope CFHQ190AL

Study Locations (3)

California

  • Veterans Affairs Palo Alto - Palo Alto
  • Veterans Affairs San Francisco - San Francisco

Missouri

  • Veterans Affairs Kansas City - Kansas City

Trial Details

FieldValue
Enrollment Target 281 participants
Start Date 2013-01
Est. Completion 2016-08
Phase NA

Sponsor

VA Palo Alto Health Care System

34 total trials

What the Registry Record Tells You About NCT01310699

The ClinicalTrials.gov registry entry for NCT01310699 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 281 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,510-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (81% lower). The listed sponsor is VA Palo Alto Health Care System, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Olympus Colonoscope CFHQ190AL is the first listed.

NCT01310699 reports 3 study locations spanning 2 distinct geographic areas - top geographies include California, Missouri.

Frequently Asked Questions

What is clinical trial NCT01310699 about?

NCT01310699 is a clinical study titled "Study of Flat Polyp Detection Using New Narrow Band Imaging (NBI) Compared to White Light Colonoscopy - The FIND FLAT Colonoscopy Study". We hypothesize that high definition narrow band imaging (NBI) colonoscopy compared to high definition white light colonoscopy will detect an increased number of nonpolypoid (flat and depressed) colorectal neoplasm.

What is the current status of trial NCT01310699?

This trial is currently completed. It is a NA study. The enrollment target is 281 participants. The study started on 2013-01. Estimated completion is 2016-08.

What conditions does trial NCT01310699 study?

This clinical trial studies the following conditions: Colorectal Cancer, Colorectal Neoplasms, Colonic Polyps.

What interventions are being tested in trial NCT01310699?

The interventions under investigation include: Olympus Colonoscope CFHQ190AL (DEVICE).

Who is sponsoring clinical trial NCT01310699?

This trial is sponsored by VA Palo Alto Health Care System, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01310699 being conducted?

This trial has 3 study locations across California, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.